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Tetracycline Protects against Dermonecrosis Induced
by Loxosceles Spider Venom
Danielle Paixa˜o-Cavalcante1, Carmen W. van den Berg2, Rute M. Gonc¸alves-de-Andrade1,
Matheus de F. Fernandes-Pedrosa1, Cinthya Kimori Okamoto1 and Denise V. Tambourgi1
Envenomation by spiders belonging to the Loxosceles genus (brown spider) often results in local
dermonecrotic lesions. We have previously shown that Loxosceles sphingomyelinase D (SMase D), the venom
component responsible for all the pathological effects, induced the expression of matrix metalloproteinases
(MMPs) in rabbits and in human keratinocytic cells. We also showed that the SMase D-induced apoptosis and
MMP expression of keratinocytes was inhibited by tetracyclines. We have further investigated the ability of
tetracyclines to inhibit or prevent the dermonecrotic lesion induced by Loxosceles venom in vivo and in vitro
models. Primary cultures of rabbit fibroblasts incubated with increasing concentrations of venom or SMase D
showed a decrease in cell viability, which was prevented by tetracyclines. In vivo experiments showed that
topical treatments with tetracycline of rabbits, inoculated with crude Loxosceles intermedia venom or
recombinant SMase D, significantly reduced the progression of the dermonecrotic lesion. Furthermore,
tetracyclines also reduced the expression of MMP-2 and prevented the induction of MMP-9. Our results suggest
that tetracycline may be an effective therapeutic agent for the treatment of cutaneous loxoscelism.
Journal of Investigative Dermatology (2007) 127, 1410–1418. doi:10.1038/sj.jid.5700688; published online 11 January 2007
INTRODUCTION
Envenomation by Loxosceles spiders is a public health
problem in Brazil and is considered the most dangerous
form of araneism in the country. Systemic reactions including
shock, hemolysis, renal insufficiency, and disseminated
intravascular coagulation are rare. In contrast, bite reactions
varying from small areas of erythema to large areas of
ulceration and necrosis are frequently observed (Futrell,
1992). The bite is relatively painless and patients often are
unaware they have been bitten. Mild to severe pain,
beginning at 2–8 hours after envenomation, is probably due
to ischemia. Erythema, with itching, swelling, and mild to
severe tenderness is also observed. At this point, the patient
might consult a physician (Futrell, 1992).
Treatment of the dermonecrotic lesion has been ineffective
and even detrimental in some cases. A variety of treatments
such as: systemic steroids, antivenom injected at lesion sites,
phentolamine, heparin, chloroprofenpyridamine maleate,
dapsone, hyperbaric oxygen, and other substances have
been used for therapy, with little or no benefit and, in some
cases, with undesirable collateral effects (Denny et al., 1964;
Dillaha et al., 1964; Rees et al., 1981; Wille and Morrow,
1988; Bitterman-Deutsch et al., 1990; Allen, 1992; Barrett
et al., 1994; Anderson, 1997; Koh, 1998; Schenone et al.,
1998; Walter et al., 1999; Bryant and Pittman, 2003; Mold and
Thompson, 2004; Elston et al., 2005; Wilson et al., 2005).
The majority of the treatments have attempted to reduce
the infiltration of polymorphonuclear (PMN) leukocytes, the
hallmark of cutaneous loxoscelism. The PMN infiltrate, in
part recruited by indirect activation of the complement
system, is considered a major contributor to tissue damage
(Ward and Cochrane, 1965; Smith and Micks, 1970; Pizzi,
1975; Sunderkotter et al., 2001; Tambourgi et al., 2005).
Treatments aiming to reduce the PMN infiltrate are fraught
with side effects and, in some cases, they can increase the
tissue injury (Wilson et al., 2005).
The low efficiency of the treatment is directly associated
with the fact that the mechanism of action of Loxosceles
venom is still not completely understood. Several studies
have indicated that sphingomyelinase D (SMase D) present in
the venoms of Loxosceles spiders is the main component
responsible for the local and systemic effects observed in
loxoscelism (Kurpiewski et al., 1981; Tambourgi et al., 1998,
2000, 2002, 2004, 2005; Fernandes-Pedrosa et al., 2002; van
den Berg et al., 2002).
We have previously shown that the binding of the SMase
D to the cell surface induces activation of endogenous
metalloproteinases of the Adamalysin family (Tambourgi
et al., 2000, 2002; van den Berg et al., 2002). Furthermore
we have recently shown that Loxosceles SMase D induces
expression of matrix metalloproteinases (MMPs) in rabbit skin
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(Tambourgi et al., 2005), as well as, in the human HaCaT
keratinocyte cell line (Paixa˜o-Cavalcante et al., 2006).
The regulation of MMPs, once they have been secreted
and activated, is a complex process. Several agents have
been developed to block the synthesis of MMPs, to prevent
their interaction with the molecules on the cell surface or to
inhibit their enzymatic activity (Engeblad and Werb, 2002).
MMP-9 has been reported to play a crucial role in the
transmigration of neutrophils, lymphocytes, and eosinophils
(Warner et al., 2001; Lee et al., 2003). Overexpression of
MMPs has been implicated in the pathogenesis of several
diseases, such as tumor progression, atherosclerotic plaque
rupture, aortic aneurisms, acute respiratory distress syn-
drome, and asthma (Ohnishi et al., 1998; Crawford and
Matrisian, 1994–95). In these diseases inhibitors of MMPs are
been used therapeutically.
The tetracycline family of antibiotics, in addition to its
antimicrobial properties, is also capable of inhibiting MMPs.
Tetracyclines and chemically modified tetracyclines have
been considered as a potential therapy for human diseases
related to MMPs ((Acharya et al., 2004). The mechanism of
action of tetracyclines results from their ability to bind metal
ions, particularly Ca2þ and Zn2þ , which are required to
maintain the correct conformation and hydrolytic activity of
the MMPs. Tetracyclines have also shown to downregulate the
synthesis and activation of MMPs (Acharya et al., 2004). In in
vitro experiments, we have recently shown that tetracyclines
can protect the human keratinocytic cell line HaCaT from
Loxosceles venom-induced MMP-2 and MMP-9 secretion and
reduction in cell viability (Paixa˜o-Cavalcante et al., 2006).
The aim of this study was to evaluate the efficacy of
tetracyclines in experimental in vivo models of loxoscelism
and the potential of this class of inhibitor as a therapeutic tool
for the treatment of the dermonecrotic lesion.
RESULTS
Loxosceles intermedia venom and SMase P2 reduce cell
viability
We have previously shown that Loxosceles venom or its main
component, the SMase D, induced apoptosis in the human
HaCaT keratinocyte cell line, which was associated with an
increased expression of metalloproteinase 2 and 9, and that
the use of metalloproteinase inhibitors, such as tetracycline,
could prevent cell death and potentially control tissue
destruction after envenomation. In order to verify if the same
occurred with rabbit fibroblast primary cultures, cells were
incubated with increasing concentrations of Loxosceles
venom or SMase D during 3 days and the cell viability
analyzed by the Alamar Blue method. Figure 1a shows that
both, venom and the recombinant SMase D (P2) were able to
induce loss of cell viability; the maximum percentage of
death (around 60%) was reached at concentrations of 15mg/
ml. Induction of apoptosis was confirmed by DNA gel
electrophoresis. DNA fragmentation was observed in samples
obtained from cells treated with venom or SMase D (Figure
1c). The same pattern of degradation was observed after
incubation with H2O2, a well-known inducer of apoptosis
(Cardoso et al., 2004).
In order to further investigate the possible association of
loss of cell viability and MMPs expression, rabbit fibroblasts
were treated with SMase D (15 mg/ml) in the presence of
increasing concentrations of tetracycline, doxycycline, or
minocycline. Figure 1b shows that the three tetracycline
derivatives at a concentration of 50 mg/ml could fully protect
the fibroblasts from the cell death induced by the venom
toxin. Treatment of the cells with 50 mg/ml of tetracycline also
prevented DNA fragmentation induced in rabbit fibroblast by
venom and SMase D, but not by H2O2 (Figure 1c).
Development of skin lesion induced by Loxosceles venom or
SMase D
Our findings of the ability of metalloproteinase inhibitor
drugs, such as tetracyclines, in controlling the noxious effects
of Loxosceles venom on the main components of the skin
such as keratinocytes (Paixa˜o-Cavalcante et al., 2006) and
fibroblasts is novel and of potential therapeutic significance,
which prompted us to investigate the use of this inhibitor in
experimental in vivo models of cutaneous loxoscelism.
Adult rabbits were inoculated with 5 mg of venom or
SMase D and the development of the skin lesion was
measured throughout a period of 48 hours. The dermonecro-
tic lesion induced by crude venom increased during the
observed period (Figure 2a and c), reaching the maximal size
at 48 hours when compared to the lesion size observed at
6 hours after inoculation. In the animals inoculated with
SMase D, the dermonecrotic lesion reached its maximum
size 12 hours after injection and decreased over the period of
48 hours (Figure 2b and d).
When the animals, inoculated with venom, were treated
twice a day during 48 hours with lanolin cream containing
tetracycline (Figure 2a) or doxycycline (Figure 2c) a significant
reduction in the development of the lesions was observed.
Similarly, topical application with tetracycline or doxycycline
inhibited the development the SMase D-induced lesion (Figure
2b and d). Oral administration of tetracycline to venom or
SMase D-injected animals was not effective in reducing the
lesion (Figure 2a and b). On the other hand, oral administra-
tion of doxycycline was capable of controlling the progression
of the dermonecrotic lesion in animals injected with venom
but not with SMase D component (Figure 2c and d). Similar
levels of lesion development inhibition were observed at
48 hours in venom-injected animals treated with doxycycline
by oral or topical routes. Oral doxycycline treatment caused a
statistically significant protection against SMase injection at
12 hours, however, after 24 hours a statistically significant
enhancement of the lesion was observed.
Statistical analysis showed that local treatment with
tetracycline and doxycycline significantly inhibited the deve-
lopment of the dermonecrotic lesion induced by Loxosceles
venom and its major toxic component, the SMase D.
Histological analysis
Rabbits were inoculated with 5 mg of L. intermedia venom,
SMase D or phosphate-buffered saline (PBS). After 6 hours of
inoculation, a typical dermonecrotic lesion was detected in
the envenomed animals and at this point the treatment with
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the tetracyclines was initiated. After 48 hours, the animals
were killed and skin specimens were obtained for histological
examination and neutrophils quantification.
Skin samples obtained from PBS-inoculated animals
showed a thin epidermis and a normal pattern for the
collagenous area and muscle fibers (Figure 3a1–d1). Skin
samples obtained from L. intermedia venom or SMase D (not
shown) inoculation sites showed a thin epidermis, dissocia-
tion of the collagenous fibers owing to the edema,
degeneration of muscle fibers, moderate hemorrhage in the
superficial dermis and intense neutrophil infiltration in the
deep dermis (Figure 3a2–d2).
Histological evaluation of the skin of the rabbits injected
with venom and treated with lanolin showed at the
inoculation site a general lesion profile similar to that
observed in non-treated animals (Figure 3a3–d3). Histological
analysis of skin sections from animals inoculated with venom
and topically or orally treated with tetracycline, although
revealing a similar dermonecrotic lesion profile at the site of
venom injection, showed no hemorrhage in the superficial
dermis (Figure 3a4–d4 and a5–d5, respectively). Moreover, no
vessel damage was observed in animals inoculated with
venom and topically treated with tetracycline (data not
shown). Figure 3a5–c5, also shows that oral tetracycline
treatment reduced the edema and prevented muscle damage.
These positive drug effects at the site of venom or SMase D
inoculation were not observed after topical or oral adminis-
tration of doxycycline (Figure 3a6–d6 and a7–d7, respec-
tively). In these treatments edema, muscle degeneration,
hemorrhage in the superficial dermis, and intense neutrophil
infiltration in the deep dermis were observed at the site of
venom inoculation.
Effect of tetracyclines on PMN infiltration
Neutrophils quantification showed that both venom
(Figure 3e2–e7) and SMase D (data not shown) induced
migration of PMN into the deep dermis. Topical treatment
with tetracycline or doxycycline reduced the number of
neutrophils found in the deep dermis of venom-injected
animals (Figure 3e4–e6, respectively; Figure 4a), but only
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Figure 1. Effect of L. intermedia venom and SMase D treatment on rabbit fibroblasts. (a) Viability: rabbit fibroblast cell cultures were incubated with increasing
concentrations of Loxosceles venom (J) or SMase D (K) and after 3 days of treatment, cell viability was analyzed by the Alamar Blue assay. (b) Effect of
tetracycline, doxycycline, and minocycline on the loss of cell viability: rabbit fibroblast cell cultures were cultivated in 24-well plates in DMEM without FBS. At
day zero, cells were treated with 15mg/ml of SMase D and simultaneously incubated with different concentrations of tetracycline (J), doxycycline (m),
or minocycline (K). After 3 days of treatment the cell viability was analyzed by the Alamar Blue assay. Results are representative for two independent
experiments and are expressed as the mean of triplicates7SD. (c) DNA gel electrophoresis: rabbit fibroblasts, cultured in DMEM without FBS, were treated with
15mg/ml of venom (V) or SMase D (P2) for 24 hours at 371C in the presence or absence of tetracycline (50mg/ml). Cells incubated with (c) PBS and H2O2
(100mM) were used as negative and positive controls, respectively. After incubation, cells were detached, washed in cold PBS, and the DNA was isolated using
Trizol reagent and analyzed by agarose gel electrophoresis.
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treatment with tetracycline reached statistical significance.
Oral treatment of venom-injected animals with tetracyclines
had no effect on PMN influx (Figure 3e5–e7; Figure 4b).
Similar results were obtained for animals inoculated with
SMase D and oral or topically treated with tetracyclines (data
not shown).
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Figure 2. Protective effect of tetracyclines on the development of dermonecrotic lesion. Adult rabbits were injected intradermally with 5 mg of venom or SMase
P2 from L. intermedia spider. After 6 hours treatments with (a and b) tetracycline or (c and d) doxycycline were initiated. The animals were treated topically (.)
with a cream containing lanolin and 5% of doxycycline or tetracycline, or orally (,) with 15 mg/kg of the inhibitors, twice a day during 48 hours. Control
animals were inoculated with venom or SMase D and not treated (K) or treated with lanolin cream alone (J). Results are representative for four independent
experiments and are expressed as the mean of triplicates7SD. The asterisks indicate values statistically different (Po0.05) from the controls, that is, non-treated,
or lanolin cream-treated venom, or SMase D-injected animals.
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Figure 3. Histological analysis of the dermonecrotic lesion induced by L. intermedia venom and SMase D after MMP inhibitors treatment. Rabbits were
injected with 5 mg of L. intermedia venom and, after 6 hours of inoculation, treated twice a day during 48 hours with tetracycline or doxycycline, as described in
Materials and Methods. Control sites were injected with an equal volume of PBS. Panels correspond to skin sections from rabbits injected with (panel 1: a–d)
PBS; (panel 2: a–d) L. intermedia venom; (panel 3: a–d) L. intermedia venom and treated with cream of lanolin alone or (panel 4: a–d) containing tetracycline or
(panel 6: a–d) doxycycline; (panel 5: a–d) L. intermedia venom and orally treated with tetracycline or (panel 7: a–d) doxycycline. Skin areas are (a) collagenous
area, (b) muscle fibers, superficial dermis: detail of (c) hemorrhage, deep dermis: detail of (d) neutrophil infiltration. Bar¼ 50 mm.
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Effect of tetracyclines on the MMPs expression
We have recently shown that Loxosceles venom and SMase
D induce an increase in the expression of MMP-9 and MMP-2
in rabbit skin and the human keratinocyte cell line HaCaT
(Tambourgi et al., 2005; Paixa˜o-Cavalcante et al., 2006). To
investigate the action of tetracyclines on MMP expression in
loxoscelism, rabbit skin sections of envenomated and control
animals, treated or not with tetracycline, or doxycycline,
were analyzed by gelatin zymography. In skin from control
rabbits only one band with gelatinolytic activity (Mr around
68 kDa; Figure 5a), was observed, which we previously
identified as MMP-2 (Tambourgi et al., 2005). As we have
previously shown, Loxosceles venom induced a band with
gelatinolytic activity (Mr around 90 kDa; Figure 5b), identi-
fied as MMP-9 (Tambourgi et al., 2005). Topical treatment of
rabbits with tetracycline or doxycycline significantly reduced
expression of MMP-2 and MMP-9 (Figure 5d and e);
tetracycline even completely prevented the induction of
MMP-9 (Figure 5d). Oral administration of tetracycline or
doxycycline did not have a large effect on expression of
gelatinases. The application of lanolin cream did not
prevent the expression of the MMPs in envenomated animals
(Figure 5c).
DISCUSSION
Envenomation by Loxosceles spiders is a well-documented
cause of necrotic skin lesions in humans. We have previously
shown that the Complement system plays an important role
in development of cutaneous loxoscelism through C5a and
membrane attack complex induced recruitment of neutro-
phils. Furthermore, Loxosceles induced expression of MMP-
9, which is possibly one of the main factors involved in the
pathogenesis of the cutaneous loxoscelism (Tambourgi et al.,
2005). We have also demonstrated that Loxosceles venom
and the SMase D provoked apoptosis in the HaCaT
immortalized keratinocyte cell line by an indirect process,
which involves an augmented expression and secretion of
MMP-2 and MMP-9 and that the metalloproteinase inhibitor
drugs, such as tetracyclines, could control in vitro the
noxious effects of Loxosceles venom associated with the
dermonecrotic process (Paixa˜o-Cavalcante et al., 2006).
Considering the novelty and potential therapeutic signifi-
cance of these results we decided to use the metalloprotei-
nase inhibitors in in vitro and in vivo rabbit model of
cutaneous loxoscelism.
Data presented here show that venom and the recombi-
nant SMase D P2 from L. intermedia spider induce reduction
of rabbit fibroblast viability, which occurred by apoptosis, as
loss of membrane asymmetry (data not shown) and DNA
degradation were detected in these cells. In our experimental
model the classic tetracycline antibiotics (tetracycline,
doxycycline, and minocycline) modulated the toxic action
of L. intermedia venom SMase D on fibroblast cells,
inhibiting the DNA degradation and thus protecting cells
from loss of viability.
These data together with our previous findings (Tambourgi
et al., 2005; Paixa˜o-Cavalcante et al., 2006) prompted us to
test these inhibitors in experimentally envenomated rabbits.
Results presented here show that tetracycline, applied on the
area of the lesion 6 hours after venom or SMase D
inoculation, largely prevented the development of the
dermonecrosis. The treatment with doxycycline, although
capable of controlling the increase of the lesion area, was less
efficient than the tetracycline. Oral administration of tetra-
cyclines had some beneficial effect in controlling the size of
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Figure 4. Determination of neutrophils number in the rabbit skin. Number of
neutrophils in the histological skin sections obtained from rabbits injected
with 5 mg of L. intermedia venom and treated twice a day with tetracycline or
doxycycline as described in Materials and Methods by (a) local or (b) oral
routes. Control animals were inoculated with venom and not treated or
treated with lanolin cream. Neutrophils quantification was performed in
histological rabbit skin sections by counting the number of cells identified by
morphological criteria. Results are representative of four different experiments
and represented as mean7SD. *Po0.05.
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Figure 5. Loxosceles venom induced gelatinases expression in skin rabbit.
Gelatinase activity was analyzed by zymography in skin samples obtained
from animals injected with (a) PBS, (b) L. intermedia venom, and (c) topically
treated with lanolin cream alone, or (d) containing tetracycline, or
(e) doxycycline, or (f) orally treated with tetracycline, or (g) doxycycline.
The arrows indicate gelatinase expression.
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the lesion of venom-injected animals, but this was not
observed for the SMase D-inoculated rabbits. The observation
that oral administration of the tetracyclines was not as
effective as the topical treatment can be due to concentration
of drug used. Experiments using higher concentrations of
tetracyclines in oral administration of normal and enveno-
mated animals will be conducted in further studies in order to
solve this question. However, higher systemic doses of
tetracycline itself may lead to toxicity.
Treatment with the tetracyclines was not able to fully
block the local inflammatory process, which was already
initiated before the start of the treatment. Although revealing
a similar dermonecrotic lesion profile at the site of venom
injection, animals treated with tetracycline in oral or topical
ways showed no hemorrhage in the superficial dermis. No
vessel damage was observed in envenomated rabbits
topically treated with tetracycline. These positive drug effects
were not observed by topical or oral administration of
doxycycline. Moreover, venom-injected animals, which were
treated with creams of tetracycline or doxycycline, showed
reduction of neutrophil infiltration.
We have previously shown (Tambourgi et al., 2005) in the
rabbit model for cutaneous loxoscelism that Loxosceles
spider venom and its SMase D induced a large influx of
neutrophils, concomitant with dissociation of the collagenous
fibres in the dermis. Decomplementation, using cobra venom
factor, largely prevented the influx of neutrophils, whereas
influx of neutrophils was also reduced in genetically C6-
deficient rabbits, suggesting roles for both C5a and the
membrane attack complex in the induction of dermonecrosis.
However, this reduction in the neutrophil influx did not
prevent the hemorrhage and the collagenous injury; whereas
induction of MMP-9 was partially reduced in complement
depleted rabbits, suggesting that neutrophils are not the only
source of MMPs. In fact, data presented here show that
fibroblasts also produce MMPs after venom/SMase contact.
Moreover, in vitro experiments using human keratinocytic
cell line HaCaT (Paixa˜o-Cavalcante et al., 2006) or primary
rabbit fibroblasts cultures (Figure 1) showed that Loxosceles
venom/SMase D induces cell death, which is associated with
an increased expression/secretion of MMP-2 and MMP-9.
The cell death and MMPs expression/secretion can be
completely inhibited by the use of tetracyclines. These data
indicate that beneficial effect of the tetracyclines involves
reduction of inflammation but also of the expression/
secretion of MMPs and consequently cell death.
Analysis of the action of tetracyclines on MMPs expression
on an in vivo model of loxoscelism, revealed that MMP-2 and
MMP-9 gelatinolytic activity induced by L. intermedia venom
was significantly reduced or abrogated by topical treatment
with tetracycline or doxycycline but not controlled by oral
administration of the drugs. These results positively correlate
with the reduction of the lesion size observed in animals
treated with the lanolin cream containing tetracycline or
doxycycline, indicating that the spreading of the dermonecro-
tic lesion may in part owing to the production of MMPs. The
development of the dermonecrotic reaction in rabbit model
could also be controlled by injecting the animals with venom
or SMase D in the presence of 1.10-phenanthroline, but not
with PMSF (inhibitor for serinoproteinase) (data not shown).
Metalloproteinases are present in healthy individuals and
have been shown to be involved in various physiological and
pathological processes. Regulation of metalloproteinases
gene expression in normal tissues is tightly controlled to
limit the biological activity. Apart from the primary function
of remodelling, the extracellular MMPs have been suggested
to play an important role in various physiological conditions
such as fetal tissue development and post-natal tissue repair,
and certain pathological conditions as periodontitis, auto-
immune disorders of skin, and dermal photoaging (Kahari and
Saarialho-Kere, 1997). The regulation of MMPs, once they
have been secreted and activated, is a complex process that
evolves a network of activation in cascade where one MMP
acts as substrate for another (Johansson et al., 2000). Of all
the pharmacological targets, inhibition of the function of
MMPs in extracellular matrix after secretion is being most
actively pursued as a potential anticancer strategy. Several
agents have been developed to block the synthesis of
MMPs, preventing the interaction with molecules that
improve their activities and direct these molecules to the
cell surface or inhibit their enzymatic activity (Engeblad and
Werb, 2002). Besides the ability of tetracyclines to inhibit
protein synthesis by binding to the 30S subunit of bacterial
ribosomes, they also have the ability to bind metal ions,
which are required by enzymes to maintain its correct
conformation and hydrolytic activity (Acharya et al., 2004).
The tetracycline derivates inhibit not only the activity but also
the production of MMPs. These agents inhibit collagenases,
MMP-1, MMP-3, and MMP-13, and gelatinases, MMP-2 and
MMP-9, via multiple mechanisms including: blocking the
activity of mature MMPs by chelation of zinc atom at the
active site; interfering with the proteolytic activation of pro-
MMP into their active form; reducing the expression of MMPs
and protecting MMPs from proteolytic and oxidative degra-
dation (Golub et al., 1998).
Recent data, utilizing rabbits as experimental models,
showed that current therapies used to treat loxoscelism like
dapsone, colchicines, triamcinolone, and diphenhydramine
were inefficient in controlling the lesion progression even
after 7 days of treatment (Elston et al., 2005) and the usual
treatments used for cutaneous loxoscelism in humans can
induce many collateral effects (Issekutz et al., 1987; Bitter-
man-Deutsch et al., 1990; Wille and Morrow, 1988).
Tetracyclines are generally well tolerated by humans and
side effects like hypersensitivity syndrome reaction, single
organ dysfunction, serum sickness-like reaction as well as
drug-induced lupus are rare occurrences associated with the
administration of these inhibitors (Shapiro et al., 1997) and
side effects are less likely to occur after topical application.
The use of tetracycline in the treatment of cutaneous
loxoscelism, has the additional advantage that, owing to its
broad spectrum antimicrobial action, it may prevent infection
of the wound.
In conclusion, we have shown here that local application
of tetracycline, 6 hours after envenomation with Loxosceles
venom (the average time point after which a patient may
www.jidonline.org 1415
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consult a physician), significantly reduces lesion formation
and MMP-2 and MMP-9 production, suggesting that tetra-
cycline may offer a valuable and relatively safe therapeutic
agent in the treatment of cutaneous loxoscelism.
MATERIALS AND METHODS
Chemicals, reagents, and buffers
Gelatin, Triton X-100, tetracycline, doxycycline, and minocycline
were purchased from Sigma (St Louis, MO). Tetracycline and
doxycycline, 5% in a hydrosoluble lanolin cream were obtained
from Biofo´rmula handle pharmacy (Sa˜o Paulo, Brazil). Trizol reagent
was from Invitrogen Inc. (Ontario, Canada).
Venom
L. intermedia Mello-Leita˜o spiders were provided by ‘‘Laborato´rio de
Imunoquı´mica, Instituto Butantan, Sa˜o Paulo, Brazil’’. The venom
was obtained by electrostimulation by the method of Bu¨cherl (1969),
with slight modifications. Briefly, 15–20 V electrical stimuli were
repeatedly applied to the spider sternum and the venom drops were
collected with a micropipette, vacuum dried, and stored at 201C.
Stock solutions were prepared in PBS (10 mM Na phosphate, 150 mM
NaCl, pH 7.2) at 1.0 mg/ml.
Sphingomyelinase expression
Recombinant L. intermedia SMase D, isoform P2 (accession number:
AY304472), was expressed in Escherichia coli strain BL21 (DE3) as a
fusion protein composed of the mature SMase with a N-terminal
extension containing a 6 histidine tag and purified as described
(Tambourgi et al., 2004).
Experimental animals
Adult New Zealand white rabbits weighing approximately 3 kg were
obtained from ‘‘Biote´rio de Animais do Instituto Butantan’’, Sa˜o
Paulo, Brazil. The animals were maintained and used under strict
ethical conditions according to the animal welfare international
recommendations. All procedures with animals were carried out in
accordance with institutionally approved protocols.
Cell culture and maintenance
Fibroblasts were isolated from adult male New Zealand rabbits by
treatment of skin sections, obtained from killed normal animals with
0.25% trypsin in DMEM (Gibco-BRL, Gaithesburg, MD) for 1 hour.
The cell suspension was filtered over sterile gauze and cells were
washed twice and cultured in DMEM supplemented with 10% (vol/
vol) heat-inactivated (561C, 30 minutes) fetal bovine serum (FBS;
Gibco-BRL), 100 IU/ml penicillin, and 100 IU/ml streptomycin at
371C in humidified air with 5% CO2. After 48 hours of culture,
medium containing non-adherent cells and debris was removed and
fresh medium was added.
Viability assay
The cell viability was analyzed by Alamar Blue Assay (Nakayama
GR et al., 1997). Briefly, rabbit fibroblasts were subcultured in 24-
well plates. Cells at 50–70% confluence at passage 5 were
maintained overnight in DMEM without FBS followed by incubation
with different concentrations of venom or SMase P2 in the presence
or absence of increasing amounts of the different metalloproteinases
inhibitors, for example, tetracycline, minocycline, or doxycycline
diluted in DMEM without FBS. DMEM without FBS was used as the
control. After 3 days of incubation, the culture supernatants were
collected and the cells were incubated with 250 ml per well of
DMEM plus 10% of Alamar Blue Reagent (Biosource International,
CA) for 1 hour at 371C. Alamar Blue added to wells not containing
cells was used as the background control. Supernatants of each
sample (100ml) were collected and mixed with 100 ml of water and
the absorbance was measured in a spectrophotometer (Multiskan-
EX, Labsystems, Finland) at 540 and 620 nm. The relative cell
viability was calculated as: ((Sample OD(540–620 nm)Background
control OD(540–620 nm))/(Control OD(540–620 nm)Background OD
(540–620 nm))) 100.
The Student’s t-test was used to determine the significance of the
differences between the mean values of cell viability from control
and experimental samples. The minimal level of significance was
considered as Po0.05.
Analysis of DNA fragmentation
Rabbit fibroblasts were treated with venom or SMase P2 (15 mg/ml)
for 24 hours and DNA was isolated using Trizol reagent (Invitrogen
Inc.), according to the manufacturer’s instructions. After 5 minutes of
incubation, chloroform was added and the samples were centrifuged
at 12,000 r.p.m. for 15 minutes at 41C. The interface containing DNA
was collected and the DNA was precipitated, washed and
solubilized in water, and analyzed by agarose gel electrophoresis.
As positive and negative controls, DNA samples were obtained from
cells treated with 100 mM of H2O2 or medium, respectively. Samples
of DNA (10 mg per well) were loaded on a 1% agarose gels
containing 1 mg/ml of ethidium bromide. The electrophoresis was
performed for 1 hour at 90 V and the DNA visualized by UV
fluorescence.
Dermonecrosis and treatment with inhibitors
Samples of 200ml of L. intermedia venom or SMase D (25mg/ml) in
PBS (pH 7.2, 10 mM Na phosphate, 150 mM NaCl) were injected
intradermally in the shaved back of rabbits. After 6 hours of
inoculation, the animals were treated with tetracycline or doxycycline
by two different schedules: (a) oral: direct administration into the
mouth (15 mg/kg in H2O) or (b) local: topical administration to the
lesion area of the hydrosoluble lanolin cream containing 5% of the
tetracyclines. Negative control groups were animals intradermally
inoculated with PBS and after 6 hours treated as the experimental
groups. Positive control groups were animals intradermally inoculated
with venom or SMase D and treated or not with hydrosoluble lanolin
(vehicle). The size of the lesions was measured 6, 12, 24, and 48 hours
following injection. The progression of the size of the lesion was
expressed as a fold increase and determined by the formula: fold
increase¼ area of the lesion at 12, 24, or 48 hours after envenomation
(in square centimeters)/lesion area at 6 hours after venom injection (in
square centimeters). The experiments were repeated four times using
three animals per group. After 48 hours, the animals were killed and
skin specimens were obtained for histological examination.
Histological analysis
Skin samples were fixed in 10% buffered formalin solution, and then
embedded in paraffin. Tissue sections were stained with hematoxylin
and eosin and examined for the presence of epithelial necrosis,
epithelial slough, dermal infiltrates, hemorrhage, and level of collagen
dissociation in the dermis and skin muscle fiber degeneration.
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Cell counting
Neutrophil quantification was performed in histological rabbit skin
sections by counting the number of cells, identified by morpho-
logical criteria, in five different areas in the dermis (18 mm2 each),
using the Image Processing and Analysis System and QWin Plus
Y2.8. program from Leica (Leica Microsytems, Cambridge, UK). The
Student’s t-test was used to determine the significance of the
differences between the mean values of cell counts obtained for
sections from control and experimental groups of rabbits. The
minimal level of significance was considered as Po0.05.
Zymography
Gelatinase activity in supernatants of homogenized skin samples was
analyzed by zymography (Kleiner and Stetler-Stevenson, 1994). Skin
samples were homogenized in SDS-PAGE sample buffer at 1 g/ml in
a tissue grinder, spun (1500 r.p.m. for 10 minutes) to pellet debris,
the supernatants were recovered, and 20 ml of each sample were run
under non-reducing conditions on a 10% polyacrylamide gel
containing 1% gelatine. The gels were washed twice for 30 minutes
at room temperature in 2.5% Triton X-100, and overnight incubated
at 371C in zymography buffer (50 mM Tris-HCl, 200 mM NaCl, 10 mM
CaCl2, 0.05% Brij-35; pH 8.3). Gels were stained in Coomassie
Brilliant Blue solution (40% methanol, 10% acetic acid, and 0.1%
Coomassie Brilliant Blue).
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